● Scientist with extensive track record in multidisciplinary, translational, biomedical & pharmaceutical research ● PhD in Biomedical Sciences (University of Nottingham, UK); BSc/MSc in Biotechnology (Immunology specialisation; University of Warsaw, Poland) ● Academic journey included visiting research fellowships in Germany/USA, and postdoctoral research at the UK’s University College London (UCL) - ranked among the world’s top 10 universities - where she worked on projects spanning nanotechnology applications in oncology, vaccines/immunotherapies, gene therapies, brain targeted delivery systems for neurodegenerative diseases ● Serves as Director of Preclinical Research & Development at Nanomerics (UCL spin out pharmaceutical company); UCL Research Affiliate ● Leads a portfolio of preclinical research programmes focused on developing nanomedicines for diverse therapeutic interventions - from oncology to neurology pipelines ● Multiple research outputs: peer reviewed publications, patents, presentations at international conferences, 13 scientific awards/grants/scholarships ● Broader scientific community engagement: Co-chair and Innovation & Enterprise Liaison for the UCL Cancer Domain Early Careers Network Committee; scientific assessor for the UCL Cancer Symposiums; reviewer for the American Association of Pharmaceutical Scientists; expert reviewer & assessor for the UKRI BBSRC Research Committees; mentor on the Royal Society of Chemistry, Wellcome Trust and CRUK programmes
● Scientist with extensive track record in multidisciplinary, translational, biomedical & pharmaceutical research ● PhD in Biomedical Sciences (University of Nottingham, UK); BSc/MSc in Biotechnology (Immunology specialisation; University of Warsaw, Poland) ● Academic journey included visiting research fellowships in Germany/USA, and postdoctoral research at the UK’s University College London (UCL) - ranked among the world’s top 10 universities - where she worked on projects spanning nanotechnology applications in oncology, vaccines/immunotherapies, gene therapies, brain targeted delivery systems for neurodegenerative diseases ● Serves as Director of Preclinical Research & Development at Nanomerics (UCL spin out pharmaceutical company); UCL Research Affiliate ● Leads a portfolio of preclinical research programmes focused on developing nanomedicines for diverse therapeutic interventions - from oncology to neurology pipelines ● Multiple research outputs: peer reviewed publications, patents, presentations at international conferences, 13 scientific awards/grants/scholarships ● Broader scientific community engagement: Co-chair and Innovation & Enterprise Liaison for the UCL Cancer Domain Early Careers Network Committee; scientific assessor for the UCL Cancer Symposiums; reviewer for the American Association of Pharmaceutical Scientists; expert reviewer & assessor for the UKRI BBSRC Research Committees; mentor on the Royal Society of Chemistry, Wellcome Trust and CRUK programmes